文献速递急性肾损伤

免疫检查点抑制剂相关急性肾损伤中的细胞因子与免疫细胞表型

Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors.
PubMed 文献 · Kidney Int Rep · 2022-12-05

一项前瞻性研究纳入24例接受免疫检查点抑制剂(ICI)治疗期间发生急性肾损伤(AKI)的患者,其中ICI相关AKI(AKI-ICI)14例、其他原因AKI(AKI-other)10例。结果发现AKI-ICI患者肾组织CD4记忆T细胞、辅助性T细胞和树突状细胞增多,尿IL-2、IL-10和TNF-α升高(P均<0.05)。尿TNF-α区分AKI病因的能力较强(AUC=0.814,95%CI 0.623-1.00)。作者认为特定T细胞反应及其细胞因子可能提示AKI-ICI,尿TNF-α是有前景的生物标志物,TNF-α通路可能作为治疗干预的潜在靶点。

要点

  • AKI-ICI患者肾组织CD4记忆T细胞、辅助性T细胞和树突状细胞较AKI-other患者增多。
  • AKI-ICI患者尿IL-2、IL-10和TNF-α较AKI-other患者升高(P均<0.05)。
  • 尿TNF-α区分AKI-ICI与AKI-other的AUC=0.814(95%CI 0.623-1.00)。

核心结论

  • 特定T细胞反应及其细胞因子可能提示ICI相关AKI,并可能有助于区分AKI-ICI与AKI-other。
  • 尿TNF-α是AKI-ICI有前景的生物标志物,AKI-ICI最常由急性间质性肾炎(AIN)引起,TNF-α通路可能作为治疗干预的潜在靶点。

研究设计与样本

  • 前瞻性研究,纳入24例在ICI治疗期间发生AKI的参与者,判定为AKI-ICI 14例或AKI-other 10例。
  • 比较两组肾脏炎症与损伤标志物(中性粒细胞明胶酶相关脂质运载蛋白、肾损伤分子-1)以及血浆和尿T细胞相关细胞因子(TNF-α、干扰素-γ、IL-2、IL-4、IL-6、IL-8、IL-9、IL-10)水平。
  • 使用质谱流式细胞术系统比较两组全身循环和肾组织中的T细胞反应。

主要发现

  • AKI-ICI患者较AKI-other患者肾组织中CD4记忆T细胞、辅助性T细胞和树突状细胞增多,尿细胞因子IL-2、IL-10和TNF-α升高(P均<0.05)。
  • TNF-α对AKI病因的区分能力较强(曲线下面积=0.814,95%置信区间:0.623-1.00)。
  • 具有记忆表型的CD4+ T细胞构成优势亚群。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Immune checkpoint inhibitors (ICIs) induce impressive antitumor responses but may lead to acute kidney injury (AKI) associated with ICI therapy (AKI-ICI). Biomarkers distinguishing AKI-ICI from AKI because of other causes (AKI-other) are currently lacking. Because ICIs block immunoregulatory pathways, we hypothesized that biomarkers related to immune cell dysregulation, including tumor necrosis factor alpha (TNF-α) and other markers of B and T cell activation in the systemic circulation and kidney tissue, may aid with the diagnosis of AKI-ICI. METHODS: This is a prospective study consisting of 24 participants who presented with AKI during ICI therapy, adjudicated to either have AKI-ICI (n = 14) or AKI-other (n = 10). We compared markers of kidney inflammation and injury (neutrophil gelatinase-associated lipocalin, kidney injury molecule-1) as well as plasma and urine levels of T cell-associated cytokines (TNF-α, interferon-γ, interleukin (IL)-2, IL-4, IL-6, IL-8, IL-9, and IL-10) between groups. We also compared T-cell responses in the systemic circulation and in kidney tissue across groups, using mass cytometry systems. RESULTS: We observed increase in several specific immune cells, including CD4 memory, T helper cells, and dendritic cells in the kidney tissue, as well as in the urine cytokines IL-2, IL-10, and TNF-α, in patients who developed AKI-ICI compared to patients with AKI-other (P < 0.05 for all). The discriminatory ability of TNF-α on AKI cause was strong (area under the curve = 0.814, 95% confidence interval: 0.623-1.00. The CD4+ T cells with memory phenotype formed the dominant subset. CONCLUSION: These results suggest that specific T-cell responses and their respective cytokines may be indicative of AKI associated with ICI therapy and may help to differentiate AKI-ICI from AKI-other. Urine TNF-α is a promising biomarker for AKI-ICI, which is most often caused by acute interstitial nephritis (AIN), and TNF-α pathway may serve as a potential target for therapeutic intervention.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Farooqui N, Zaidi M, Vaughan L, et al. Cytokines and Immune Cell Phenotype in Acute Kidney Injury Associated With Immune Checkpoint Inhibitors. Kidney Int Rep. 2022. PMID: 36938084. doi:10.1016/j.ekir.2022.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。